Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis
Trial details
- Registry ID
- NCT03680131
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact DermatitisNCT03680131 | EDSA | Phase 2 | Completed | 2022-09-21Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |